Clinical trials
Phase 4 Nausea trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
| Terminated | 12 |
| Unknown status | 7 |
| Withdrawn | 5 |
| Not yet recruiting | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| Radboud University Medical Center | 3 |
| Columbia University | 2 |
| Montefiore Medical Center | 2 |
| Pontificia Universidad Catolica de Chile | 2 |
| Rutgers, The State University of New Jersey | 2 |
| University Health Network, Toronto | 2 |
| Yonsei University | 2 |
| Ankara University | 1 |
| Aristotle University Of Thessaloniki | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nausea | 84 |
| Vomiting | 62 |
| Postoperative Nausea and Vomiting | 16 |
| Pain | 11 |
| Postoperative Pain | 6 |
| Pruritus | 6 |
| Neoplasms | 5 |
| Abdominal Pain | 4 |
| Constipation | 4 |
| Hypotension | 3 |
Trials
Showing 76 to 84 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.